ArticleHepatology (Baltimore, Md.)2026

Population perspectives on benefits and harms of screening for metabolic dysfunction-associated steatotic liver disease.

Alina M Allen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.